THRD Net Income Growth
-258.49%TTM
Period ending:
THRD TTM Net Income YoY %%
99.67%-296.86%
2022-12-312025-03-31
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
THRD net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 10 observations from Dec 31, 2022 to Mar 31, 2025.
| Period ending | Net Income Growth |
|---|---|
| -258.4882% | |
| -181.7511% | |
| -70.7081% | |
| 53.1135% | |
| 61.2944% | |
| 56.6358% | |
| 41.6275% | |
| 0.0078% | |
| -12.7374% | |
| -25.6881% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All THRD financial metrics · THRD stock overview · How to interpret financial metrics